Partnering for Innovative Drug Development

Lever Bio is a newly launched initiative promoted by Claris Ventures and Exor Ventures, with the aim to collaborate with top researchers to drive innovative drug development programs.

​

Operating in partnership with universities and research centers, Lever Bio finances early preclinical projects and fosters scientific synergy to efficiently address clinical needs.

​

Lever Bio offers both expertise in drug development and global business development network aiming to be the premier partner for researchers exploring new therapeutic opportunities.